Treatment of a cyclic tripalladium(II) complex, [Pd3(d-pen)3] (d-H2pen: d-penicillamine), with l-methionine (l-Hmet) gave a novel open-chain-type S-bridged heptapalladium(II) complex, [Pd7(d-pen)8(l-met)2]4−, besides a monopalladium(II) complex, [Pd(d-pen)(l-met)]−. A similar reaction using S-methyl-l-cysteine (l-Hsmc) instead of l-Hmet produced an analogous heptapalladium(II) complex, [Pd7(d-pen)8(l-smc)2]4−.
The reactions of an S-bridged trinuclear palladium(II) complex, [Pd(3)(D-pen-N,O,S)(3)] (D-H(2)pen = D-penicillamine), with ethylenediamine (en) and racemic (R,R/S,S) 1,2-cyclohexanediamine (chxn) in water gave mononuclear palladium(II) complexes, [Pd(D-pen-N,S)(en)] (1) and [Pd(D-pen-N,S)(chxn)] (2), respectively. Of two diastereomers, [Pd(D-pen-N,S)(R,R-chxn)] (2(R)) and [Pd(D-pen-N,S)(S,S-chxn)] (2(S)), possible for 2, 2(S) was exclusively isolated in a high yield.
The asymmetric unit of the title compound, [Pd4(C5H9NO2S)4]·9.75H2O, contains two neutral tetranuclear complex molecules with similar conformations and 19.5 solvent water molecules. Of the 21 independent water molecules, three exhibit an occupancy of one-half. In each tetranuclear complex molecule, the four PdII atoms have a square-planar coordination environment and are spanned by four d-penicillaminate ligands in a κ4
N,S:S,O coordination mode, forming an eight-membered Pd4S4 metallacycle. In the crystal, two tetranuclear molecules are connected to each other through eight N—H⋯O hydrogen bonds between amine and carboxylate groups, constructing a cylindrical dimer. The dimers are further hydrogen-bonded with the solvent water molecules, completing a three-dimensional network.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.